July 10, 2014 10:46 PM ET

Biotechnology

Company Overview of Kosan Biosciences Incorporated

Company Overview

Kosan Biosciences Incorporated, a cancer therapeutics company, focuses on developing various classes of anticancer agents through clinical development. Its product KOS-953, a Hsp90 inhibitor is in Phase III clinical trial in combination with Velcade for multiple myeloma, as well as in Phase II clinical trial in combination with Herceptin for HER2-positive metastatic breast cancer. The company’s product portfolio also includes KOS-1584, an epothilone anticancer product candidate evaluated in dose-escalating Phase I clinical trial in patients with solid tumors; KOS-1803, a preclinical stage product for cancer; KOS-2187, a potent motilin receptor agonist that is in Phase I clinical testing for ...

3832 Bay Center Place

Hayward, CA 94545

United States

Founded in 1995

91 Employees

Phone:

510-732-8400

Fax:

510-732-8401

Key Executives for Kosan Biosciences Incorporated

Co-Founder
Age: 49
Co-Founder and Advisor
Age: 72
Chief Financial Officer
Age: 54
Senior Vice President of Manufacturing & Operations
Age: 50
Senior Vice President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Sunol Molecular Corporation United States
Terpenoid Therapeutics Incorporated United States
Genescient Corporation United States
Avantome, Inc. United States
Intarcia Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kosan Biosciences Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.